Merck’s $8 billion cancer vaccine faces first U.S. jury trial
Lawyers weigh the side effects of “Naked Drug Regulators” and launched misleading marketing campaigns to turn the drug into blockbuster. Read more:
Report
Similar Posts
Caterpillar CHRO Cheryl Johnson to retire in April By Investing.com
IRVING, TX – Caterpillar Inc. (NYSE: NYSE: ), a global leader in construction and mining equipment…
ZETA FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Zeta Global Holdings Corp. Investors to Secure Counsel Before Important January 21 Deadline in Securities Class Action
New York, NY–(Newsfile Corp. – January 10, 2025) – WHY? The Rosen Law Firm, a global…
Mortgage rates rise, hitting demand
Kudlow panelists Steve Forbes, David Bahnsen and Jackie DeAngelis explore the state of the US economy…
Fed members back slower pace of rate cuts, Fed’s minutes show By Investing.com
Investing.com – Federal Reserve policymakers favored slowing the pace of interest rate cuts amid concerns about…
Wisa Technologies’ officer sells $4,046 in stock By Investing.com
In the most recent transactions reported to the SEC, Stanley Mbugua, chief accounting officer and VP…
English